全文获取类型
收费全文 | 217510篇 |
免费 | 3147篇 |
国内免费 | 366篇 |
专业分类
耳鼻咽喉 | 1577篇 |
儿科学 | 7399篇 |
妇产科学 | 4241篇 |
基础医学 | 21537篇 |
口腔科学 | 3218篇 |
临床医学 | 15580篇 |
内科学 | 42816篇 |
皮肤病学 | 1572篇 |
神经病学 | 20105篇 |
特种医学 | 9959篇 |
外科学 | 35151篇 |
综合类 | 2468篇 |
一般理论 | 9篇 |
预防医学 | 20365篇 |
眼科学 | 3409篇 |
药学 | 11752篇 |
中国医学 | 737篇 |
肿瘤学 | 19128篇 |
出版年
2023年 | 320篇 |
2022年 | 775篇 |
2021年 | 1466篇 |
2020年 | 792篇 |
2019年 | 1129篇 |
2018年 | 23228篇 |
2017年 | 18184篇 |
2016年 | 20413篇 |
2015年 | 2165篇 |
2014年 | 2542篇 |
2013年 | 3047篇 |
2012年 | 10417篇 |
2011年 | 24287篇 |
2010年 | 20623篇 |
2009年 | 13098篇 |
2008年 | 22285篇 |
2007年 | 24548篇 |
2006年 | 3388篇 |
2005年 | 4990篇 |
2004年 | 5899篇 |
2003年 | 6592篇 |
2002年 | 4475篇 |
2001年 | 525篇 |
2000年 | 581篇 |
1999年 | 438篇 |
1998年 | 557篇 |
1997年 | 517篇 |
1996年 | 365篇 |
1995年 | 374篇 |
1994年 | 310篇 |
1993年 | 219篇 |
1992年 | 176篇 |
1991年 | 182篇 |
1990年 | 222篇 |
1989年 | 158篇 |
1988年 | 117篇 |
1987年 | 94篇 |
1986年 | 97篇 |
1985年 | 99篇 |
1984年 | 91篇 |
1983年 | 87篇 |
1982年 | 118篇 |
1981年 | 67篇 |
1980年 | 110篇 |
1978年 | 55篇 |
1976年 | 43篇 |
1974年 | 49篇 |
1938年 | 63篇 |
1932年 | 59篇 |
1930年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
961.
Small CB Hernandez J Reyes A Schenkel E Damiano A Stryszak P Staudinger H Danzig M 《The Journal of allergy and clinical immunology》2005,116(6):1275-1281
BACKGROUND: Studies have suggested that topical corticosteroids are effective in the treatment of nasal polyps; however, this has yet to be confirmed in a large, robust clinical trial. OBJECTIVE: To evaluate the efficacy and safety of mometasone furoate nasal spray (MFNS) for nasal polyposis. METHODS: A total of 354 subjects with bilateral nasal polyps and clinically significant congestion/obstruction participated in this multinational, randomized, double-blind, placebo-controlled study. Subjects received MFNS 200 microg once or twice daily or placebo for 4 months. Coprimary endpoints were (1) change from baseline to last assessment in physician-evaluated bilateral polyp grade score and (2) change from baseline averaged over month 1 in subject-assessed nasal congestion/obstruction. ANOVA was used for all efficacy endpoints, except for change in bilateral polyp grade score, for which baseline polyp grade was added as a covariate. RESULTS: Compared with placebo, MFNS 200 microg administered once or twice daily produced significantly greater reductions in bilateral polyp grade score (P < .001, P = .010, respectively) and congestion/obstruction (P = .001, P < .001), as well as improvement in loss of smell (P < .001, P = .036), anterior rhinorrhea (P < .001 for both), and postnasal drip (P < .001, P = .001) over month 1. MFNS 200 microg twice daily was superior to MFNS 200 microg once daily in reducing congestion/obstruction (P = .039), and there were more improvers in the MFNS 200 microg twice daily group (P = .035). MFNS was well tolerated in both groups. CONCLUSION: MFNS 200 mug, once or twice daily, was safe and significantly superior to placebo in reducing polyp grade (size and extent) and improving congestion/obstruction and return of sense of smell. MFNS is an effective medical treatment for nasal polyposis and may reduce or delay the need for surgery. 相似文献
962.
Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen,but not by the LACK antigen,are protective against experimental Leishmania (Leishmania) amazonensis infection 下载免费PDF全文
Coelho EA Tavares CA Carvalho FA Chaves KF Teixeira KN Rodrigues RC Charest H Matlashewski G Gazzinelli RT Fernandes AP 《Infection and immunity》2003,71(7):3988-3994
Leishmania amazonensis is one of the major etiologic agents of a broad spectrum of clinical forms of leishmaniasis and has a wide geographical distribution in the Americas, which overlaps with the areas of transmission of many other Leishmania species. The LACK and A2 antigens are shared by various Leishmania species. A2 was previously shown to induce a potent Th1 immune response and protection against L. donovani infection in BALB/c mice. LACK is effective against L. major infection, but no significant protection against L. donovani infection was observed, in spite of the induction of a potent Th1 immune response. In an attempt to select candidate antigens for an American leishmaniasis vaccine, we investigated the protective effect of these recombinant antigens (rLACK and rA2) and recombinant interleukin-12 (rIL-12) against L. amazonensis infection in BALB/c mice. As expected, immunization with either rA2-rIL-12 or rLACK-rIL-12 induced a robust Th1 response prior to infection. However, only the BALB/c mice immunized with rA2-rIL-12 were protected against infection. Sustained gamma interferon (IFN-gamma) production, high levels of anti-A2 antibodies, and low levels of parasite-specific antibodies were detected in these mice after infection. In contrast, mice immunized with rLACK-rIL-12 displayed decreased levels of IFN-gamma and high levels of both anti-LACK and parasite-specific antibodies. Curiously, the association between rA2 and rLACK antigens in the same vaccine completely inhibited the rA2-specific IFN-gamma and humoral responses and, consequently, the protective effect of the rA2 antigen against L. amazonensis infection. We concluded that A2, but not LACK, fits the requirements for a safe vaccine against American leishmaniasis. 相似文献
963.
Alicja Gryczyńska-Siemiątkowska Alicja Siedlecka Joanna Stańczak Miłosława Barkowska 《Acta parasitologica / Witold Stefański Institute of Parasitology, Warszawa, Poland》2007,52(2):165-170
Sand lizards (Lacerta agilis) were trapped and examined for ticks from May to September in 2002 and 2003 in Northeastern Poland. A total of 233 Ixodes ricinus (L.) ticks (76 larvae and 157 nymphs) was found on 31 of 235 captured lizards (13.2%). The tick infestation is relatively
low compared to that of mammals and passerine birds from the same area (Siński et al. 2006, Gryczyńska et al. 2002). Tick infestation depended on the month of capture, being the highest in spring. In autumn no ticks were recorded on
any of the captured lizards. The oldest lizards carried the highest number of ticks but no differences related to sex of the
host were found. All the collected ticks were analysed by PCR for the presence of Borrelia burgdorferi sensu lato, the etiological agents of Lyme disease. Spirochetes were detected in 11 out of 233 (4.7%) ticks tested. Genetic
analysis confirmed that the spirochetes are members of the Borrelia afzelii, B. garinii and B. burgdorferi sensu stricto genospecies. Mixed infection were not detected. The prevalence of infection was analysed in relation to months
of the capture, age and sex of the lizards, but differences were not statistically significant. The obtained results suggest
that lizards are probably not B. burgdorferi reservoirs, but further studies are required to confirm this. 相似文献
964.
Brian R Lawson Stanley M Belkowski John F Whitesides Paul Davis John W Lawson 《BMC complementary and alternative medicine》2007,7(1):20
Background
Rheumatoid arthritis (RA) and its accepted animal model, murine collagen-induced arthritis (CIA), are classic autoimmune inflammatory diseases which require proinflammatory cytokine production for pathogenesis. We and others have previously used N, N-dimethylglycine (DMG) and extracts from the New Zealand green-lipped mussel Perna canaliculus (Perna) as potent immunomodulators to modify ongoing immune and/or inflammatory responses. 相似文献965.
Antonio Marchetti Fiamma Buttitta Salvatore Girlando Paolo Dalla Palma Silvia Pellegrini Paolo Fina Claudio Doglioni Generoso Bevilacqua Mattia Barbareschi 《The Journal of pathology》1995,175(1):31-38
This study investigates the mdm2 gene status and expression in 66 surgically resected human breast carcinomas, with correlations with clinico-pathological and biological data (histological type, grading, steroid receptor status, p53 expression, proliferative activity). Four (7.7 per cent) out of 52 informative cases bear mdm2 gene amplification (four- to ten-fold) and 8 (15.4 per cent) of 52 cases showed borderline amplification (three-fold). Nine (13.6 per cent) out of 66 cases showed strong mdm2 nuclear immunoreactivity. Twenty-seven (40.9 per cent) cases showed isolated mdm2 reactive nuclei. All cases with clear amplification showed a high percentage of mdm2 immunoreactive nuclei. The relationship between gene amplification and mdm2 protein expression is highly significant (P<0.0001). No association was observed between mdm2 gene amplification and any of the considered clinico-pathological and biological parameters, while mdm2 immunoreactivity showed a significant association only with oestrogen receptor immunoreactivity (P=0.009). p53 expression was associated neither with mdm2 gene amplification nor with mdm2 immunoreactivity. It could be tempting to hypothesize that the evaluation of the combined mdm2/p53 immunohistochemical phenotype in human breast carcinoma could give us better prognostic information than the evaluation of the expression of the p53 protein alone. 相似文献
966.
Patrick Tan 《BMC medicine》2008,6(1):27
Identifying the complete repertoire of genes and genetic variants that regulate the pathogenesis and progression of human
disease is a central goal of post-genomic biomedical research. In cancer, recent studies have shown that genome-wide association
studies can be successfully used to identify germline polymorphisms associated with an individual's susceptibility to malignancy.
In parallel to these reports, substantial work has also shown that patterns of somatic alterations in human tumors can be
successfully employed to predict disease prognosis and treatment response. A paper by Van Ness et al. published this month
in BMC Medicine reports the initial results of a multi-institutional consortium for multiple myeloma designed to evaluate the role of germline
polymorphisms in influencing multiple myeloma clinical outcome. Applying a custom-designed single nucleotide polymorphism
microarray to two separate patient cohorts, the investigators successfully identified specific combinations of germline polymorphisms
significantly associated with early clinical relapse. These results raise the exciting possibility that besides somatically
acquired alterations, germline genetic background may also exert an important influence on cancer patient prognosis and outcome.
Future 'personalized medicine' strategies for cancer may thus require incorporating genomic information from both tumor cells
and the non-malignant patient genome. 相似文献
967.
Ludovico Dipineto Antonio Gargiulo Luigi M. De Luca Bossa Laura Rinaldi Luca Borrelli Lucia F. Menna 《Avian pathology》2008,37(5):507-508
The present study was undertaken with the aim to evaluate the prevalence of thermotolerant Campylobacter spp. in living pheasants in Italy. To achieve this goal, a total of 240 living pheasants, equally shared between female and male birds, were examined. Thermotolerant Campylobacter spp. was isolated in 104 out of 204 (43.3%) living pheasants analysed. Campylobacter coli (100%) and Campylobacter jejuni (13.5%) were identified by polymerase chain reaction. Adult pheasants showed a significantly higher prevalence value (P < 0.05) than younger pheasants. 相似文献
968.
We have known for some time that the epidemiology of human stroke is sexually dimorphic until late in life, well beyond the
years of reproductive senescence and menopause. Now, a new concept is emerging: the mechanisms and outcome of cerebral ischemic injury are influenced strongly by biological sex as well as the availability of sex steroids to the
brain. The principal mammalian estrogen (17 β estradiol or E2) is neuroprotective in many types of brain injury and has been
the major focus of investigation over the past several decades. However, it is becoming increasingly clear that although hormones
are a major contributor to sex-specific outcomes, they do not fully account for sex-specific responses to cerebral ischemia.
The purpose of this review is to highlight recent studies in cell culture and animal models that suggest that genetic sex
determines experimental stroke outcome and that divergent cell death pathways are activated after an ischemic insult. These
sex differences need to be identified if we are to develop efficacious neuroprotective agents for use in stroke patients. 相似文献
969.
970.
Eriksson E Dons L Rothfuchs AG Heldin P Wigzell H Rottenberg ME 《Infection and immunity》2003,71(7):4102-4111